ArcticZymes Technologies announces closing of Biotec BetaGlucans divestment

Tromsø, Norway, 31. December 2020. With reference to announcement made on 14. December 2020, ArcticZymes Technologies ASA (AZT) announces closing of the Biotec BetaGlucans AS divestment. Under the terms of the share purchase agreement (SPA) signed between ArcticZymes Technologies ASA and Lallemand Inc’s subsidiary, Danstar Ferment AG, all closing conditions are fulfilled. In line with the SPA, ArcticZymes Technologies has …

ArcticZymes Technologies divests Biotec BetaGlucans subsidiary to Lallemand

Tromsø, Norway, 14. December 2020. ArcticZymes Technologies ASA (AZT) has today entered into a Share Purchase Agreement (SPA) with Lallemand Inc’s subsidiary, Danstar Ferment AG for the divestment of AZT’s Biotec BetaGlucans AS subsidiary (BBG) The transaction is based on an Enterprise Value of NOK 70 Million payable in cash at closing – expected end of December 2020 and which …

Vacant positions in ArcticZymes

With our expanding product portfolio and development, we are in seacrh of 3 new employees to help us grow. Please see details for further information QC Technician (application deadline 23 November) Production Technician (application deadline 23 November) Production Assistant (application deadline 23 November)

Q3 2020 Presentation and report

Tromsø, Norway, 22 October 2020 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 30.8 million (22.5) and an EBITDA of NOK 10.1 million (0.8) for the third quarter of 2020. Underlying growth continues. Highlights from Q3 2020 Annual group sales exceed 100 MNOK for the first time Gross profit for the Group improved 65% to NOK 26.0 million (Q3 …